Clinical trial · Interventional
Green Tea Combined With Chemotherapy in the Treatment of Advanced Non-small Cell Lung Cancer
Green Tea Combined With Chemotherapy in the Treatment of Advanced Non-small Cell Lung Cancer: A Randomized, Controlled Multicenter Clinical Study
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): There are no suitable participants
Summary
Brief summary (as posted)
Patients with non-small cell lung cancer who met the inclusion and exclusion criteria were screened and randomly divided into control group and experimental group. Control group: chemotherapy plus water ,test group: chemotherapy plus green tea. Primary endpoint: Assessment of changes in quality of life (QOL) after chemotherapy according to FACT-L (4th edition). A clinically significant change in the quality of life of lung cancer was defined as a FACT-L score change of ≥6 points from baseline, with \<6 points defined as no clinically significant changes;
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Non-small Cell Lung Cancer | Lung Non-Small Cell Carcinoma | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| green tea | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- PLACEBO_COMPARATOR
- label
- Control group
- description
- chemotherapy plus water
- interventionNames
- Other: green tea
- type
- EXPERIMENTAL
- label
- Test group
- description
- chemotherapy plus green tea
- interventionNames
- Other: green tea
Primary outcomes (1)
- measure
- Quality of life (QOL) according to FACT-L (4th edition).
- timeFrame
- 4-5 months
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients with pathologically confirmed NSCLC have evaluable lesions. * ECOG PS：0-2分。 * Unintentional liver and kidney and other organic diseases, no other primary malignant tumors. * Patients with clinical stage IIIB and IV who are scheduled for chemotherapy (first or second line). Exclusion Criteria: * Patients who have long-term tea drinking habits (more than 4 cups of green tea per day). * Patients who have used immunological checkpoint inhibitors for more than 50%. Pregnant or lactating woman. * The investigator judges other conditions that may affect the clinical research and the judgment of the research results.
References
Publications (0)
Data not yet available